Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Your GP can refer you to a specialist weight management service
The GLP-1 injection site guide covers optimal locations and rotation strategies
Circulation 143(21):e984e1010 Lopez-Jimenez F, Almahmeed W, Bays H et al (2022) Obesity and cardiovascular disease: mechanistic insights and management strategies
10th November 2024 Understanding Pancreatitis Risk with Mounjaro Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist designed to improve blood sugar control and support weight management
Inflammatory Bowel Disease (IBD): Conditions such as ulcerative colitis and Crohns disease can cause inflammation and ulcers in the digestive tract, leading to anorectal bleeding
At 50% uptake, and assuming a 15.5% discontinuation rate as observed in the SOUL trial, an estimated 59,332 MACE, 14,215 cardiovascular deaths, 41,744 nonfatal myocardial infarctions, and 12,260 nonfatal strokes could be prevented
